The newest
Bio-convergence
Bio-convergence
We’re excited to be back for another episode of the by Healthcare IT Today. My guest today is Shai Melcer, Head of the National Program for Bioconvergence at . We kick this episode off by first learning what bioconvergence is. Then we talk about who The Israel Innovation Authority’s customers are. Next, we examine why this is such a unique opportunity for Israel. But no opportunity is without its competition, so we talk about how Melcer is competing with cyber and defense — which are huge sectors here. Melcer then also shares how he is competing against big companies like Sandbox AQ. Next, we discuss how The Israel Innovation Authority creates and captures value. Lastly, we conclude this episode with Melcer sharing three things he wants to do for his customers.
Startup Funding
Startup Funding
Hanan Brand the Vice President and head of the Startup Division at the Israel Innovation Authority. He is responsible for giving grants to hundreds of early-stage Israeli startups. Avraham and sat down with Hanan to discuss what the Innovation Authority does, how to be in the 25% that get a grant, lessons he’s learned over the years, why Israeli is the startup nation and much more.
Bio-convergence
Bio-convergence
In this episode of the ILTV News Podcast with Executive Editor Maayan Hoffman, we sit down with Dr. Shai Melcer, head of Israel’s National Bio-Convergence Program at the Israel Innovation Authority. With 15 years in the biomedical ecosystem, Dr. Melcer explains what bio-convergence really means—and why it’s set to transform healthcare, climate solutions, food security, and more. Discover how Israel is becoming a global leader in this cutting-edge field, the startups driving breakthroughs, and what the future could hold.
AI
ILTV News Podcast | The Secret Behind Israel’s Dominance in AI Innovation
In the latest episode of the ILTV News Podcast, Executive Editor Maayan Hoffman sits down with Ziv Katzir, head of the National Infrastructure Forum for Research and Development in AI at the Israel Innovation Authority, to explore how the industry is shaping up in Israel.
Bio-convergence
We’re excited to be back for another episode of the by Healthcare IT Today. My guest today is Shai Melcer, Head of the National Program for Bioconvergence at . We kick this episode off by first learning what bioconvergence is. Then we talk about who The Israel Innovation Authority’s customers are. Next, we examine why this is such a unique opportunity for Israel. But no opportunity is without its competition, so we talk about how Melcer is competing with cyber and defense — which are huge sectors here. Melcer then also shares how he is competing against big companies like Sandbox AQ. Next, we discuss how The Israel Innovation Authority creates and captures value. Lastly, we conclude this episode with Melcer sharing three things he wants to do for his customers.
In this episode of the ILTV News Podcast with Executive Editor Maayan Hoffman, we sit down with Dr. Shai Melcer, head of Israel’s National Bio-Convergence Program at the Israel Innovation Authority. With 15 years in the biomedical ecosystem, Dr. Melcer explains what bio-convergence really means—and why it’s set to transform healthcare, climate solutions, food security, and more. Discover how Israel is becoming a global leader in this cutting-edge field, the startups driving breakthroughs, and what the future could hold.
Dr. Shai Melcer, Ph.D. is Head of the National Bioconvergence Program at the Israel Innovation Authority.
In this role, Dr. Melcer, who brings 15 years of experience and entrepreneurship in the bio-medical ecosystem, leads the implementation of the bioconvergence goals for TELEM – the National Infrastructure Forum for Research and Development.
Dr. Melcer has both an LLM in Law and Ph.D. in genetics from the Hebrew University, and has collaborated with various entities such as the Hebrew University, Hadassah Medical Center, IBM, the Jerusalem Development Authority (Bio-Jerusalem), and others to establish numerous innovative bio-med ventures, including BioGiv, BIOHOUSE, and Hadassah Accelerator.
Startup Funding
Hanan Brand the Vice President and head of the Startup Division at the Israel Innovation Authority. He is responsible for giving grants to hundreds of early-stage Israeli startups. Avraham and sat down with Hanan to discuss what the Innovation Authority does, how to be in the 25% that get a grant, lessons he’s learned over the years, why Israeli is the startup nation and much more.